ALXN1840
Alexion
['alx']
danny bega, md, will present efficacy and safety of alxn1840 versus standard of care in wilson disease: primary results from an ongoing phase 3, randomized, controlled, rater-blinded trial today, starting at 9:45 am et. learn more: 
Dept. of Neurology @NorthwesternMed @NUFeinbergMed. Northwestern Memorial Hospital among top 10 in U.S. for Neurology and Neurosurgery for 10th year by @USNews.